Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CASK antisense RNA 1 (CASK-AS1) is a long non-coding RNA transcribed from the antisense strand opposite the CASK gene locus. As a member of the antisense lncRNA family, CASK-AS1 is believed to be involved in the regulation of gene expression, particularly affecting its sense gene, CASK, which encodes a multi-domain scaffolding protein implicated in neurodevelopment and synaptic function. Although aberrant lncRNA expression is broadly linked with various human diseases, specific functional or therapeutic relevance for CASK-AS1 is not well-established. It is mainly studied as a regulatory RNA with disease associations based on linked protein-coding genes, not as a drug target itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CASK antisense RNA 1 (CASK-AS1).